Here we are again — lacing up our sneakers, rallying our people, and raising money for the Atlanta Miles for Melanoma 5K and the Melanoma Research Foundation. And after the year we’ve had, those miles mean a little more.
Last year was kind of a big deal. Our dear friend John Gibby Galvin took SECOND PLACE! And Adam? ADAM WAS THE #1 FUNDRAISER. That happened because of YOU — our ridiculously generous family, friends, cheerleaders, donors, and all-around amazing humans. So naturally, we have only one reasonable response: LET’S DO IT AGAIN.
Not convinced? Keep reading.
What started as spots in Adam’s vision in June 2025 led to a diagnosis we never expected. In August, doctors discovered a medium-sized tumor in his left eye. After being diagnosed with uveal melanoma, a type of ocular cancer, he underwent plaque radiation therapy in October and has continued with scans every three months to monitor for any signs that the cancer has spread. It’s been a journey filled with uncertainty, but we’re incredibly grateful for Adam’s care team and for everyone who has supported us along the way.
Ocular melanoma is a rare type of cancer that develops in the pigment-producing cells of the eye, It is the most frequent primary cancer inside the eyeball for adults, though it remains very rare with about 5 cases per million people each year. Advances in detection, treatment, and survival have changed what a melanoma diagnosis can mean, but there is still much research needed for ocular melanoma.
Every scan. Every treatment option. Every breakthrough. None of it happens in a vacuum. It happens because researchers keep pushing . Doctors keep learning. Patients keep fighting. Families and friends keep showing up. And because people like you decide to help. The finish line may still be ahead of us, but it feels closer than it once did.
So this year, we’re asking you to step up with us again. Donate. Walk. Run. Cheer. Share. Send good vibes. Hey, you could even challenge Adam’s fundraising crown if you dare.
Every step matters. Every dollar counts.
Help make ocular melanoma a disease that someday nobody has to fear.
